LUNGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Pulmonx Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$1.75−0.03 (-1.69%)
Close on Oct 19, 2026
- Market cap
- $74.32M
- P/E (TTM)
- –
- Dividend yield
- –
Pulmonx Corp revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $14.18M | $13.26M | $14.10M | $13.97M | $14.73M | $14.22M | $15.88M | $13.84M | $13.88M | $12.87M | $13.72M | $11.84M | 62.3% | -3.8% |
| EMEA | $7.73M | $6.57M | $7.88M | $6.63M | $7.00M | $5.48M | $6.12M | $5.13M | $5.96M | $5.12M | $4.64M | $4.85M | 34.0% | +10.4% |
| Asia Pacific | $726.00K | $707.00K | $565.00K | $842.00K | $2.03M | $2.80M | $1.66M | $1.28M | $802.00K | $698.00K | $821.00K | $814.00K | 3.2% | -64.2% |
| Other International | $126.00K | $51.00K | $52.00K | $68.00K | $102.00K | $38.00K | $101.00K | $145.00K | $139.00K | $171.00K | $96.00K | $164.00K | 0.6% | +23.5% |
From the segment and revenue-disaggregation notes of Pulmonx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.